ImmunityBio revenue and financials
$9.86Change from previous close: −5.01%Absolute change: −$0.52
In the fiscal year ended December 2025, ImmunityBio reported revenue of $113.29M (+668.31% year over year). The net loss was $351.4M.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +668.31%
- 2025 vs 2024
- Net margin
- -310.2%
- 2024: -2,804.8%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 629 | 647 | 502 | 519 | 402 | 304 | 383 | 365 | 444 | 401 | 504 | 432 |
| Current assets | 439 | 453 | 315 | 329 | 208 | 109 | 185 | 163 | 243 | 196 | 294 | 215 |
| Cash and equivalents | 75.7 | 205 | 88.3 | 60.2 | 138 | 60.7 | 143 | 112 | 130 | 133 | 265 | 178 |
| Short-term investments | 282 | 176 | 154 | 198 | 16.0 | 0.9 | 6.4 | 18.4 | 87.9 | 37.5 | 1.0 | 11.8 |
| Receivables | 53.5 | 43.3 | 42.6 | 33.7 | 22.3 | 17.5 | 2.7 | 4.9 | 2.1 | 2.1 | 3.2 | 2.3 |
| Inventory | 1.9 | 0.5 | 0.9 | 6.7 | 6.6 | 8.4 | 8.3 | 2.0 | 1.8 | — | — | — |
| Net property, plant and equipment | 146 | 146 | 148 | 163 | 168 | 167 | 170 | 174 | 176 | 179 | 183 | 188 |
| Goodwill | — | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | — | — | — | — |
| Other intangible assets | 11.8 | 12.0 | 13.0 | 13.6 | 14.1 | 14.5 | 15.0 | 15.6 | 16.1 | 16.6 | 17.1 | 18.5 |
| Long-term investments | — | — | 14.2 | 0.7 | 0.7 | 0.7 | 0.7 | — | — | — | 0.9 | 0.8 |
| Current liabilities | 76.7 | 68.0 | 61.8 | 57.1 | 50.6 | 49.2 | 54.9 | 61.0 | 62.1 | 53.8 | 58.3 | 90.3 |
| Accounts payable | 12.0 | 11.2 | 7.0 | 5.8 | 7.4 | 13.5 | 6.7 | 9.9 | 20.3 | 13.9 | 9.2 | 19.8 |
| Long-term debt | 1,189 | 1,083 | 802 | 817 | 799 | 782 | 746 | 973 | 956 | 851 | 837 | 674 |
| Total debt | 813 | 719 | 518 | 542 | 535 | — | — | — | — | — | — | — |
| Total liabilities | 1,674 | 1,516 | 1,001 | 1,042 | 972 | 894 | 871 | 1,109 | 1,142 | 1,092 | 1,090 | 843 |
| Total equity (incl. minority) | -1,046 | -869 | -500 | -523 | -570 | -590 | -488 | -744 | -697 | -691 | -586 | -411 |
| Retained earnings | -4,590 | -4,359 | -3,727 | -3,665 | -3,597 | -3,505 | -3,375 | -3,316 | -3,230 | -3,096 | -2,962 | -2,728 |
| Minority interest | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 1.1 | 1.1 |